Netherlands· NL-e342a81a5cec

Beryx 20 mg, maagsapresistente tabletten

A rabeprazole product containing rabeprazolnatrium, registered in Netherlands by Krka d.d., Novo mesto. The same ATC class is registered in 17 of our 19 countries.

ATC A02BC04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about rabeprazolnatriumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Rabeprazole is registered in 17 of 19 countries.

Countries holding a registration under ATC A02BC04 (rabeprazole), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search rabeprazole products by name

Rabeprazole · ATC A02BC04

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rabeprazole costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.13 in France to $0.85 in Switzerland — a ×6.4 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Rabeprazole · price per daily dose (10 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.85
ES Spain$0.50
IT Italy$0.24
FR France$0.13

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: RABEPRAZOLNATRIUM
Manufacturer: Krka d.d., Novo mesto
Country: Netherlands (NL)
ATC code: A02BC04
ATC class: Rabeprazole
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
105708

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

592 interactions on record for rabeprazole.

Graded by severity as the source publishes them — 22 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check rabeprazole against other medicines How interaction checks work

Rabeprazole · interactions on record

592 records

22 severe
107 moderate
27 minor
427 info

Most severe, free to view

ClopidogrelB01AC04severe
NelfinavirJ05AE04severe
AtazanavirJ05AE08severe
RilpivirineJ05AG05severe

9 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rabeprazole in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rabeprazole products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Pariet, Rabeprazol 1a Pharma
Belgium · Pariet
Bulgaria · Ацилесол, Зулбекс
Cyprus · Pariet, Rabeprazole Krka
Czechia · Rapoxol, Zulbex
Germany · Pariet, Rabeprazol Puren
Denmark · Pariet, Rabeprazol Medical Valley
Estonia · Rabeprazole Actavis, Rabeprazole Doc Generici
Spain · Pariet, Rabeprazol Almus
Finland · Pariet, Rabeprazol Krka
France · Pariet, Rabeprazole Almus
United Kingdom (Northern Ireland) · Pariet, Rabeprazole Accord Healthcare
Greece · Aircodos, Berlex
Croatia · Ares, Zulbex
Hungary · Acilesol, Gelbra
Ireland · Pariet, Rabeprazole Krka
Iceland · Pariet, Rabeprazol Actavis
Italy · Akirab, Pariet
Lithuania · Rabeprazole Actavis, Yzilan
Luxembourg · Pariet
Latvia · Rabeprazole Adoh, Zulbex
Malta · Pariet
Poland · Zulbex
Portugal · Pariet, Rabeprazol Aurovitas
Romania · Relitaz, Zulbex
Sweden · Pariet
Slovenia · Rabeprazol Lek, Zulbex
Slovakia · Zulbex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/3c08b907-af29-4498-985f-f10691135c2c
GET /v1/drugs/3c08b907-af29-4498-985f-f10691135c2c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Maagsapresistente tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h105708_smpc.pdf",
  "strength": null,
  "atc_label": "Rabeprazole",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg105708",
  "excipients": [
    "ETHYLCELLULOSE (E 462)",
    "HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSEFTALAAT",
    "IJZEROXIDE GEEL (E 172)",
    "MAGNESIUMOXIDE, LICHT (E 530)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "MONOGLYCERIDEN, GEDIACETYLEERD",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "RABEPRAZOLNATRIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h105708.pdf",
  "authorised_at": "2010/09/14",
  "procedure_number": "NL/H/1788/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "105708",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about rabeprazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console